Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Agenus Inc. is a clinical-stage biotechnology firm operating globally, dedicated to the discovery and development of immuno-oncology therapies.

52W Range

81stpctl

Volume

0.23×avg

Market Cap

318.98MUSD

P/E Ratio

2.8TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Agenus Inc.

AGENNASDAQ Capital Market·USD·Closed

Agenus Inc.

AGENNASDAQ·USD·Closed

$7.66

−1.92%

$7.66

−$0.15 (1.92%)

52W Range

81stpctl

Volume

0.23×avg

Mkt Cap

318.98MUSD

P/E

2.8TTM

Div Yield

–ann

AGEN: Agenus Inc. Stock Analysis | finqOS